Gilead Sciences

ISIN US3755581036

WKN 885823

Market cap (in EUR)

116.838,74 m

Country

Verenigde Staten

Sector

Gezondheidszorg

Dividend yield

2,91%

Overview

Quote

Trade with your broker

Description

Gilead Sciences, Inc. is een biofarmaceutisch bedrijf dat zich bezighoudt met het onderzoek naar, de ontwikkeling van en het op de markt brengen van geneesmiddelen op gebieden waar nog geen medische behoefte bestaat. Het bedrijf richt zich voornamelijk op het menselijk immunodeficiëntievirus, het verworven immunodeficiëntiesyndroom, leverziekten, hematologie, oncologie en ontstekings- en ademhalingsziekten. Het biedt antivirale producten aan onder de merknamen Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi en Vosevi. Het bedrijf werd op 22 juni 1987 opgericht door Michael L. Riordan en het hoofdkantoor is gevestigd in Foster City, CA.

Show more Show less

Gezondheidszorg Biofarmaceutica Niet-SysteemspecifiekeÂ Biofarmaceutica Verenigde Staten

Chart

30/04/2024 - 30/04/2025

Add ETF for comparison

Show more chart settings

Financials

Key metrics

Market capitalisation, EUR	116.838,74 m
EPS, EUR	4,43
P/B ratio	6,95
P/E ratio	22,42
Dividend yield	2,91%

Income statement (2024)

Revenue, EUR	26.557,39 m
Net income, EUR	443,75 m
Profit margin	1,67%

What ETF is Gilead Sciences in?

There are 462 ETFs which contain Gilead Sciences. All of these ETFs are listed in the table below. The ETF with the largest weighting of Gilead Sciences is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

Show entries

Search:

ETF	Weight	Investment focus	Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF	10,12%	Equity United States Health Care Biotech	368
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	10,12%	Equity United States Health Care Biotech	23
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Acc)	4,30%	Equity World Health Care Social/Environmental	88
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist)	4,30%	Equity World Health Care Social/Environmental	443
First Trust NYSE Arca Biotechnology UCITS ETF Acc	4,15%	Equity United States Health Care Biotech	7
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C	3,79%	Equity World Health Care Social/Environmental	31
iShares Nasdaq 100 ex-Top 30 UCITS ETF USD (Acc)	3,56%	Equity United States Technology	7
VanEck Morningstar US Wide Moat UCITS ETF A	3,41%	Equity United States Equal Weighted Moat	45
WisdomTree US Equity Income UCITS ETF Acc	3,31%	Equity United States Dividend	73
WisdomTree US Equity Income UCITS ETF EUR Hedged Acc	3,31%	Equity United States Dividend	1

Showing 1 to 10 of 462 entries

1 2 3 4 5…47

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.

Select your savings amount:

Execution fee	Account fee
0.00€	0.00€	View offer*
0.00€	0.00€	View offer*
0.00€	0.00€	View offer*

Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.

Performance

Returns overview

YTD	+4.39%
1 month	-9.55%
3 months	-0.15%
6 months	+14.78%
1 year	+53.19%
3 years	+65.81%
5 years	+24.53%
Since inception (MAX)	+0.75%
2024	+22.62%
2023	-7.82%
2022	+22.39%
2021	+40.04%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).